المؤلفون: Gholam-Reza Esfandiari, Azad Maroufi, Fariba Ghebleh, Amirhossein Modabbernia, Shamsali Rezazadeh, Raofeh Ghayyoumi, Bahman Salehi, Shahin Akhondzadeh, Mehrangiz Naderi, Mina Tabrizi, Farzin Rezaei

المصدر: Psychopharmacology. 213(4)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Sildenafil, Placebo-controlled study, behavioral disciplines and activities, Piperazines, Sildenafil Citrate, law.invention, chemistry.chemical_compound, Young Adult, Pharmacotherapy, Randomized controlled trial, Double-Blind Method, law, Internal medicine, mental disorders, medicine, Humans, Prospective Studies, Sulfones, Psychiatry, Prospective cohort study, Pharmacology, Psychiatric Status Rating Scales, Risperidone, business.industry, food and beverages, Middle Aged, Phosphodiesterase 5 Inhibitors, medicine.disease, respiratory tract diseases, chemistry, Schizophrenia, Purines, cGMP-specific phosphodiesterase type 5, cardiovascular system, Drug Therapy, Combination, Female, Schizophrenic Psychology, business, medicine.drug, Antipsychotic Agents

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d14cb944e85ab8ba933f37881683ff1d
https://pubmed.ncbi.nlm.nih.gov/21193982